University Hospitals Cleveland Medical Center

University Hospitals Surpasses $5 Million in Community Support in Fight Against COVID-19

Community foundations lead with substantial grant funding

Newswise — CLEVELAND – More than $5 million in community giving is helping to support University Hospitals’ response to the ongoing COVID-19 health crisis. Contributions from community hospital foundations, totaling $2.25 million, and a $1 million clinical research grant from the Cleveland Foundation represent a significant portion of the funds contributed to date and will provide crucial, local-level support during the pandemic.

“Our caregivers are making untold sacrifices to meet this challenge unlike any other in our lifetimes,” said Thomas F. Zenty III, CEO, University Hospitals. “While this pandemic may feel daunting, we have a resilient team and a dedicated community who are all demonstrating strength beyond measure.”

Challenge grants of $500,000 each – awarded by Elyria Medical Center Foundation, Parma Hospital Health Care Foundation, Portage Medical Center Foundation and Samaritan Hospital Foundation – will support the COVID-19 Community Response Funds at each of the foundation’s affiliated UH medical centers. Leading by example, the four hospital foundations hope the new challenge grants inspire others to join them in supporting their local UH medical centers.

“During this unprecedented time, I think all of us at community hospital foundations feel the same – it is crucial that we show our support for our local UH medical centers and the dedicated caregivers that work there,” said Richard Beal, President, Samaritan Hospital Foundation.

An additional $250,000 gift from Rainbow Babies & Children’s Foundation will help UH’s nationally recognized children’s hospital withstand the COVID-19 crisis and emerge strong. “It is vitally important that we help UH Rainbow face this challenge head-on and ensure that they’re well-positioned to meet the post-crisis needs of our patients and families,” said Rainbow Foundation President, Terri A. Kennedy.

Recognizing the unprecedented challenges faced by caregivers at health systems throughout Northeast Ohio and the critical role they will continue to play in ensuring the recovery and resilience of the community, the Cleveland Foundation authorized $1 million in emergency funding from previously restricted health-related research grant dollars to support a significant portion of a UH-led clinical trial of ARMS-I, an investigational drug that may prevent airborne transmission of coronavirus. The ARMS-I study is one of the COVID-19-related trials and research initiatives underway at the academic medical center thanks to critical research support from the UH COVID-19 Community Response Fund.

In addition to local community foundations, individuals, corporations and family foundations across the region have responded to the crisis with overwhelming compassion, generously supporting UH’s COVID-19 Community Response Fund and COVID-19 Caregiver Support Fund. Contributions to the two funds – including lead donations from the Vinchel Family, Amy and Michael Southard, Bank of America and Hyundai Hope on Wheels – are helping defray the unanticipated costs of the health crisis, ranging from extensive patient care and testing, medical supplies and research to providing for the protection, wellness and resilience of UH caregivers.

Donations of personal protective equipment, critical care supplies and homemade fabric facemasks – cumulatively valued at more than $500,000 – are further supporting UH and its frontline caregivers.

“University Hospitals has a long-standing commitment to the health and well-being of our community, a promise that we extended in recent years with the health system’s regional expansion,” said UH Chief Operating Officer, Eric Beck, DO, MPH. “Today, that promise is more important than ever and we are grateful to have wide-spread support throughout Northeast Ohio and beyond as we face this pandemic together.”

Community members can learn about ways to support UH and its caregivers during the COVID-19 health crisis at UHGiving.org/coronavirus.

###

 About University Hospitals

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UH’s vision for benefitting its patients into the future, and the organization’s unwavering mission is To Heal. To Teach. To Discover. Follow UH on LinkedIn, Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, visit UHhospitals.org.

 




Filters close

Showing results

2130 of 3821
Released: 28-Oct-2020 11:05 AM EDT
SARS-CoV-2 outbreak investigation in meat processing plant suggests aerosol transmission in confined
European Molecular Biology Organization (EMBO)

The importance of maintaining high quality air flow to restrict transmission of SARS-CoV-2 in confined workspaces has been strongly indicated by the investigation of an outbreak of the virus at a German meat processing plant during May and June 2020.

Released: 28-Oct-2020 10:35 AM EDT
New Johns Hopkins Center for Research on COVID-19 Immunity
Johns Hopkins Bloomberg School of Public Health

Researchers at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine have been jointly awarded a major grant from the National Cancer Institute, part of the National Institutes of Health, to set up a center for research on the human serological immune response to SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 28-Oct-2020 10:30 AM EDT
Halloween predicted to be down 41% this year
Michigan State University

New data from Michigan State University predicts that trick-or-treating could be down approximately 41% for households with children under 14 due to COVID-19.

Newswise: Life and Livelihood as the Pandemic Drags On
Released: 28-Oct-2020 10:25 AM EDT
Life and Livelihood as the Pandemic Drags On
The Electrochemical Society

When we started on our COVID-19 interview series, no one knew how long the pandemic would last or the long-term impact it would have on our community. As we approach the end of a year of living in the shadow of COVID-19, we thought it useful to follow up with some of our interviewees. We learned that research, collaboration, teaching, and learning are continuing to evolve—along with the challenges of distance learning, meeting, and life.

Newswise: Forty Studies Later, a Keck Medicine of USC Radiologist Reveals What He Has Learned About COVID-19
Released: 28-Oct-2020 9:00 AM EDT
Forty Studies Later, a Keck Medicine of USC Radiologist Reveals What He Has Learned About COVID-19
Keck Medicine of USC

Ali Gholamrezanezhad, MD, a clinical emergency radiologist with Keck Medicine of USC, was one of the first researchers to study COVID-19 in early 2020. Today, Gholamrezanezhad has co-authored more than 40 papers on the disease, gathering and analyzing a wide array of data and patient scans. He offers his unique insights into a virus that has infected more than 43 million people worldwide.

Newswise: Study: Turning a coronavirus protein into a nanoparticle could be key to an effective COVID-19 vaccine
Released: 28-Oct-2020 8:55 AM EDT
Study: Turning a coronavirus protein into a nanoparticle could be key to an effective COVID-19 vaccine
University at Buffalo

One of the proteins on the virus – located on the characteristic COVID spike – has a component called the receptor-binding domain, or RBD, which is its “Achilles heel.” That is, he said, antibodies against this part of the virus have the potential to the neutralize the virus.

Released: 28-Oct-2020 3:20 AM EDT
Risk score predicts prognosis of outpatients with COVID-19
Massachusetts General Hospital

A new artificial intelligence-based score considers multiple factors to predict the prognosis of individual patients with COVID-19 seen at urgent care clinics or emergency departments.

Released: 28-Oct-2020 1:10 AM EDT
Swiss fatalism protects against negative feelings in the pandemic
University of Zurich

Trust or disappointment in government crisis management is an important factor for the general mood, shows a study by the University of Zurich based on surveys in Israel and Switzerland.

Released: 28-Oct-2020 12:05 AM EDT
Low-cost airlines have adapted best to COVID-19
Universitat Oberta De Catalunya (UOC)

The COVID-19 pandemic has caused a dramatic reduction in travel, especially to other countries.


Showing results

2130 of 3821

close
1.00773